A study in European Heart Journal yesterday shows a 23% lower risk of cardiovascular events in recipients of the shingles ...

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

The formulation allows for greater stockpiling, with Bavarian Nordic already working with the US Government to add to vaccine reserves.

Exercised options total USD 143.6 million; Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026; COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/ ...

A recent study carried out at Charité Universitätsmedizin Berlin and published in The Lancet Infectious Diseases has shown that one dose of Bavarian Nordic’s Jynneos (smallpox and mpox vaccine ...

China's first monkeypox vaccine has entered phase I clinical trials at a hospital in Central China's Henan Province and plans to recruit volunteers aged 18 and above in Zhengzhou, capital of the ...

“Even in light of these promising data, we strongly recommend people receive two doses of Jynneos vaccine spaced out 28 days apart to ensure durable, lasting immune protection against monkeypox ...

Health officials are advising people at higher risk of mpox infection to consider being vaccinated with two doses of the JYNNEOS vaccine, which is available statewide. Laboratory testing of the ...

Mpox is a rare, but potentially serious, viral illness that typically involves flu-like symptoms, swollen lymph nodes and a rash that includes bumps that are filled with fluid before scabbing ...

Other vaccines to be discussed at the meeting include the mpox vaccine Jynneos from Bavarian Nordic (OTCPK:BVNKF), (BAVN) (OTCPK:BVNRY), Moderna’s (NASDAQ:MRNA) next-gen COVID shot mRNA-1283 ...

Also, their recently FDA-approved freeze-dried Jynneos vaccine and EU/US-approved chikungunya vaccine launches are near-term growth catalysts. BVNKF’s 2025 outlook also suggests they still have ...

Exercised options total USD 143.6 million Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026 COPENHAGEN, Denmark, May 6, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced ...